SCHEMBL25968808

SCHEMBL25968808

CS(=O)(=O)N1CCc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.51
ESR1 P03372 2/20 0.48
ESR2 Q92731 2/20 0.48
HDAC6 Q9UBN7 1/20 0.43
AKR1C3 P42330 2/20 0.43
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
RYR2 Q92736 1/20 0.41
PKM P14618 1/20 0.40
CYP2D6 P10635 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GHSR Q92847 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31565850 0.89 MAPT (0.43) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL31566044 0.89 CA7 (0.47) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL31566031 0.87 GHSR (0.41) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL31566080 0.87 RORC (0.45) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL31566088 0.87 HDAC6 (0.43) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL1265546 0.87 ESR1 (0.55) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL31565858 0.85 HDAC6 (0.42) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL25968867 0.85 HDAC6 (0.44) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL29950631 0.85 HDAC6 (0.42) HRH3ESR1ESR2HDAC6AKR1C3
SCHEMBL27173113 0.85 HDAC6 (0.42) HRH3ESR1ESR2HDAC6AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-04-24 US disclosed
WO-2023147063-A2 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR YAP1, YES1, LATS1 HRH3 1373/4885ESR1 998/4885ESR2 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.